BioPharm
International The dynamic field of vaccines continues to evolve. Long-forgotten infectious diseases are once again serious prospects for new vaccines, and at the same time, companies continue their hot pursuit of therapeutic vaccines. Adjuvant development is advancing along with delivery techniques, and manufacturers continue to optimize formulations, stabilization techniques, characterization methods, and purification strategies. This supplement will examine this evolution and explore the future of vaccine development.
>>> The ad close for this supplement issue is
September 15 <<<
>>> The material due date is September 21
<<<
|
THE EVOLUTION OF VACCINES EDITORIAL HIGHLIGHTS |
-
Evolution of Live-Attenuated HIV vaccines
-
Tetrahymena thermophila as an Alternative Platform for Rapid Production of Effective Subunit Vaccines
-
Characterization of Aluminum Hydroxide Gel and Oil-in-Water Emulsion Formulations Containing CpG ODNs
-
Sterilizing Filtration of Adjuvanted Vaccines: Ensuring Successful Filterability and Bacterial Retention Validation Studies
-
Release and Stability Testing Programs for a Novel Virus-Like Particle Vaccine
Contact Your Representative
Pat Venezia Jr.
732-346-3011
pvenezia@advanstar.com
James Gray
44(0)1244 393101
jgray@advanstar.com
| 
